Share Email Print

Proceedings Paper

ALA-mediated photodynamic therapy of experimental malignant glioma in the BD-IX rat model
Author(s): Henry Hirschberg; Even Angell-Petersen; Qian Peng; Chung-Ho Sun; Dag R. Sorensen; Steven W. Carper; Steen J. Madsen
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Introduction: Failure of treatment for high grade gliomas is usually due to local recurrence at the site of surgical resec-tion indicating that a more aggressive form of local therapy could be of benefit. Photodynamic therapy (PDT) is a local form of treatment involving the administration of a tumor-localizing photosensitizing drug that is activated by light of a specific wavelength The results of in vitro experiments indicated that PDT, given at low fluence rates was substantially more effective at inhibiting glioma spheroid growth than short term high fluence rate regimes. This prompted the initia-tion of in vivo studies of low fluence rate 5-aminolevulinic acid (ALA) PDT in a rat glioma model. Methods:BT4C cell line tumors were established in the brains of inbred BD- IX rats. Eighteen days following tumor induction the animals were injected with 125 mg/kg ALA ip. and four hours later light treatment at various fluences and fluence rates were given after the introduction of an optical fiber. Tumor histology and animal survival were examined. Results: In vitro experiments verified that the cell line was sensitive to ALA PDT. Microfluorometry of frozen tissue sections showed that PpIX is produced with a greater than 20:1 tumor to normal tissue selectivity ratio four hours after ALA injection. Histological examination demonstrated neutrophil infiltration and tumor central necrosis in low fluence rate treated tumors. Conclusions: Low fluence rate long term ALA mediated PDT had a more pronounced effect on tumor histology than single shot short duration treatments at similar total fluence levels.

Paper Details

Date Published: 25 April 2005
PDF: 9 pages
Proc. SPIE 5686, Photonic Therapeutics and Diagnostics, (25 April 2005); doi: 10.1117/12.591760
Show Author Affiliations
Henry Hirschberg, Rikshospitalet (Norway)
Univ. of Nevada/Las Vegas (United States)
The Norwegian Radium Hospital (Norway)
Even Angell-Petersen, The Norwegian Radium Hospital (Norway)
Qian Peng, The Norwegian Radium Hospital (Norway)
Chung-Ho Sun, Beckman Laser Institute, Univ. of California/Irvine (United States)
Dag R. Sorensen, Rikshospitalet (Norway)
Steven W. Carper, Univ. of Nevada/Las Vegas Cancer Research Ctr. (United States)
Univ. of Nevada/Las Vegas (United States)
Steen J. Madsen, Univ. of Nevada/Las Vegas (United States)
Univ. of Nevada/Las Vegas Cancer Research Ctr. (United States)

Published in SPIE Proceedings Vol. 5686:
Photonic Therapeutics and Diagnostics
Brian Jet-Fei Wong M.D.; Eugene A. Trowers M.D.; Kenton W. Gregory M.D.; Abraham Katzir; Nikiforos Kollias; Reza S. Malek M.D.; Henry Hirschberg M.D.; Kenneth Eugene Bartels D.V.M.; Steen J. Madsen; Lloyd P. Tate V.D.M.; Lawrence S. Bass M.D.; Werner T. W. de Riese; Karen M. McNally-Heintzelman, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?